NCT04829110

Brief Summary

The study is cross-sectional is design. In the first Aim of this study, 5 women and 5 men will be asked to consume 2g/kg of \[2H\]water (a.k.a. deuterium oxide or heavy water) which incorporates 2H tracers into newly synthesized fatty acids and triglycerides. Deuterated water is not radioactive and has a long history of application in human studies. Researchers will collect blood samples 2 hours before and 5 hours after the participants consume 20 grams of alcohol as vodka to measure alcohol induced hepatic de novo lipogenesis (DNL) in both men in women. In addition, for Aim 2 researchers will recruit an additional 10 women who will be randomized into one of two groups who will consume a beverage containing vodka and sucrose, or sucrose alone. Aim 2 will be identical to the experimental scheme in Aim 2 in order to determine if sucrose enhances the effects of vodka on hepatic DNL.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for not_applicable

Timeline
11mo left

Started Nov 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Nov 2021Mar 2027

First Submitted

Initial submission to the registry

March 18, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 2, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

November 11, 2021

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2027

Last Updated

May 7, 2026

Status Verified

April 1, 2026

Enrollment Period

5.4 years

First QC Date

March 18, 2021

Last Update Submit

April 30, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mean Change in Hepatic De Novo Lipogenesis (DNL)

    DNL will be measured by Orbitrap high-resolution-mass-spectrometry (GC-Orbitrap-HRMS) We will measure changes in the incorporation of 2H tracers into plasma triglycerides over time. This data will be analyzed by averaging each time point and looking at change in de novo lipogenesis over time.

    0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, and 7 hours post heavy water consumption

Study Arms (3)

A. ETOH

EXPERIMENTAL

5 Males and 5 Females will receive deuterated water and drink 2.15 ounces of alcohol in the form of vodka and have de novo Lipogenesis measured at 11 time points during and after.

Other: ETOH

ETOH + Sucrose

EXPERIMENTAL

5 Females will receive deuterated water and drink 1.72 ounces of alcohol in the form of vodka + 7 grams of sucrose and have de novo Lipogenesis measured at 11 time points during and after.

Other: ETOHOther: Sucrose

C. Sucrose

EXPERIMENTAL

5 Females will receive deuterated water and drink a solution containing water and 35 grams of sucrose, and have de novo Lipogenesis measured at 11 time points during and after.

Other: Sucrose

Interventions

ETOHOTHER

Participants will consume Vodka

Also known as: Vodka
A. ETOHETOH + Sucrose
SucroseOTHER

Participants will consume sucrose in solution with water

Also known as: Sucrose solution
C. SucroseETOH + Sucrose

Eligibility Criteria

Age21 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male or Female
  • Ages 21 - 45
  • Healthy
  • Light to moderate alcohol consumption (≤1 drink a day (\~14g) in women and ≤2 drinks a day (\~28 g) in men)
  • BMI between 18.5-29.9
  • Normal Nutritional Status
  • Ability to speak and understand English

You may not qualify if:

  • BMI \>29.9
  • Comorbid conditions
  • Any regular medications, except Oral Contraceptives
  • Pregnant or Breastfeeding
  • Regular exercise above activities of daily living

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Health Professions at UTSW

Dallas, Texas, 75390, United States

Location

MeSH Terms

Interventions

Sucrosesodium lactobionate sucrose solution

Intervention Hierarchy (Ancestors)

DisaccharidesOligosaccharidesPolysaccharidesCarbohydratesSugars

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 18, 2021

First Posted

April 2, 2021

Study Start

November 11, 2021

Primary Completion (Estimated)

March 31, 2027

Study Completion (Estimated)

March 31, 2027

Last Updated

May 7, 2026

Record last verified: 2026-04

Locations